Repligen Corp. (RGEN)
165.18
+0.50
(+0.30%)
USD |
NASDAQ |
Sep 11, 16:00
165.00
-0.18
(-0.11%)
After-Hours: 20:00
Repligen Market Cap : 9.321B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 9.321B |
| September 10, 2026 | 9.292B |
| September 09, 2026 | 9.313B |
| September 08, 2026 | 9.510B |
| September 04, 2026 | 9.457B |
| September 03, 2026 | 9.571B |
| September 02, 2026 | 9.759B |
| September 01, 2026 | 9.594B |
| August 31, 2026 | 10.21B |
| August 28, 2026 | 9.946B |
| August 27, 2026 | 10.27B |
| August 26, 2026 | 10.17B |
| August 25, 2026 | 10.25B |
| August 24, 2026 | 10.25B |
| August 21, 2026 | 10.22B |
| August 20, 2026 | 10.17B |
| August 19, 2026 | 9.951B |
| August 18, 2026 | 9.375B |
| August 17, 2026 | 9.538B |
| August 14, 2026 | 9.414B |
| August 13, 2026 | 9.451B |
| August 12, 2026 | 9.350B |
| August 11, 2026 | 9.297B |
| August 10, 2026 | 9.207B |
| August 07, 2026 | 9.248B |
| Date | Value |
|---|---|
| August 06, 2026 | 8.997B |
| August 05, 2026 | 8.949B |
| August 04, 2026 | 8.452B |
| August 03, 2026 | 8.298B |
| July 31, 2026 | 7.957B |
| July 30, 2026 | 8.103B |
| July 29, 2026 | 7.969B |
| July 28, 2026 | 8.201B |
| July 27, 2026 | 7.395B |
| July 24, 2026 | 7.446B |
| July 23, 2026 | 7.764B |
| July 22, 2026 | 7.901B |
| July 21, 2026 | 7.726B |
| July 20, 2026 | 8.206B |
| July 17, 2026 | 8.305B |
| July 16, 2026 | 8.378B |
| July 15, 2026 | 8.350B |
| July 14, 2026 | 8.298B |
| July 13, 2026 | 8.171B |
| July 10, 2026 | 8.135B |
| July 09, 2026 | 8.118B |
| July 08, 2026 | 7.750B |
| July 07, 2026 | 7.886B |
| July 06, 2026 | 7.978B |
| July 02, 2026 | 8.031B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLife Solutions, Inc. | 1.709B |
| Anika Therapeutics, Inc. | 279.17M |
| Danaher Corp. | 140.68B |
| Liquidia Corp. | 5.947B |
| Harmony Biosciences Holdings, Inc. | 2.413B |
Market Cap Related Metrics
| PE Ratio | 225.13 |
| PS Ratio | 11.91 |
| Price to Book Value | 4.413 |
| Price to Free Cash Flow | 84.91 |
| Price | 165.18 |
| Earnings Yield | 0.44% |
| Operating PE Ratio | 131.87 |
| Normalized PE Ratio | 202.38 |